Dialysis Patients' Perspectives: A Study of the Q Methodology
1 other identifier
observational
26
1 country
1
Brief Summary
This study was conducted to systematically examine the subjective experiences and perspectives of dialysis patients regarding their treatment modalities.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Jul 2025
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 31, 2025
CompletedFirst Submitted
Initial submission to the registry
December 22, 2025
CompletedFirst Posted
Study publicly available on registry
January 8, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 31, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
January 31, 2026
CompletedMarch 12, 2026
March 1, 2026
6 months
December 22, 2025
March 11, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Perception of dialysis treatment
Hemodialysis patients were asked to rank 24 Q items, developed based on literature review and clinical experience, on a scale from -3 (strongly disagree) to +3 (strongly agree) according to a normal distribution model.
up to 6 months
Eligibility Criteria
The hospital where the study will be conducted has a total of 13 adult peritoneal dialysis patients and 70 adult hemodialysis patients who regularly receive dialysis treatment and attend follow-up appointments. The aim is to study the entire peritoneal dialysis patient population. For hemodialysis patients, a similar number of patients (n=13) to the peritoneal dialysis patients will be selected using a simple randomization method, and these patients will be included in the study.
You may qualify if:
- Being between 18-65 years of age,
- Being able to read and write,
- Not having vision or hearing problems,
- Voluntary participation in our study,
- Being conscious,
- Being a patient with end-stage renal failure,
- Not having communication problems
You may not qualify if:
- Wishing to withdraw from the research.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Sbu. Van Training and Research Hospital
Van, Turkey (Türkiye)
Study Officials
- PRINCIPAL INVESTIGATOR
Yavuz Uren, PhD
Yuzuncu Yil University
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- OTHER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Inverstigator
Study Record Dates
First Submitted
December 22, 2025
First Posted
January 8, 2026
Study Start
July 31, 2025
Primary Completion
January 31, 2026
Study Completion
January 31, 2026
Last Updated
March 12, 2026
Record last verified: 2026-03